Micardis
Indicated to manage hypertension, designed to target blood pressure elevation.
Strengths: 20 · 40 · 80mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Telmisartan Tablets
- Therapeutic class
Angiotensin II Receptor Antagonist
- Pharmacological class
Sartan
- Known off-label uses
cardiovascular risk reduction
- Precautions and warnings
monitor renal function; may cause dizziness; consider effect on potassium levels
- Minor side effects
dizziness; fatigue; back pain
- Moderate side effects
hyperkalaemia; hypotension; impaired renal function
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
Indicated to manage hypertension, designed to target blood pressure elevation.
- Prescription status
POM
- Manufacturer
Boehringer Ingelheim
- Onset Time
1–2 hours
- Duration
24 hours
- Storage instructions
Store below 30°C.
- Drug interactions
potassium-sparing diuretics; potassium supplements; lithium; aliskiren
- Age restrictions
Not recommended for children under 18 years.
Contraindications
severe hepatic impairment; biliary obstruction; pregnancy; co-administration with aliskiren in patients with diabetes
Serious side effects
angioedema — requires immediate medical attention; acute renal failure — requires immediate medical attention
Mechanism of action
Telmisartan is an angiotensin II receptor antagonist that blocks the binding of angiotensin II to the AT1 receptor, resulting in reduced vasoconstriction and aldosterone secretion, thereby lowering blood pressure.
Pregnancy and breastfeeding
Pregnancy: Contraindicated as it may cause damage to the developing foetus. Breastfeeding: Not recommended.
Micardis
Indicated to manage hypertension, designed to target blood pressure elevation.
Editorial Notes
- Active ingredient(s): Telmisartan
- Listed indication(s): Hypertension
Usually available as
- 120 tablets - 20 mg720-20-mg-3510
- 90 tablets - 40 mg720-40-mg-3518
- 30 tablets - 80 mg720-80-mg-3522